EPIDEMIOLOGICAL PROFILE OF CHLAMYDIA TRACHOMATIS INFECTION IN LOW-INCOME PREGNANT WOMEN IN KINSHASA

A cross-sectional study conducted in Kinshasa between June and December 2023 revealed an 18% prevalence of *Chlamydia trachomatis* infection among low-income pregnant women, with the highest rates observed in married women aged 25–35 and significant associations with vaginal symptoms and adverse pregnancy outcomes such as prematurity and spontaneous abortion.

The Gist

Imagine a quiet, invisible intruder living inside the bodies of many pregnant women in Kinshasa, the capital of the Democratic Republic of Congo. This intruder is a tiny bacterium called Chlamydia trachomatis. It's like a "ghost" infection: it often doesn't make a sound or show a face, but if left unchecked, it can cause serious trouble for both the mother and her baby.

This paper is a report card from a team of scientists who decided to shine a flashlight on this ghost. Here is what they found, explained simply:

1. The Mission: Catching the Ghost

The researchers went to a maternity ward in a poor neighborhood in western Kinshasa. Think of this area as a place where life is hard, resources are scarce, and many people don't have much money. They wanted to answer a simple question: "How many pregnant women here are carrying this invisible bacteria?"

They didn't just guess; they used a high-tech "magnifying glass" called PCR testing. Imagine trying to find a specific needle in a haystack. Instead of looking with your eyes, they used a machine that amplifies the DNA of the bacteria, making it loud enough to be heard. They took samples from 239 women, but after checking the quality of the samples (like making sure the water in a glass is clear enough to drink), they ended up with 161 perfect samples to study.

2. The Findings: Who is the Ghost Visiting?

The results were a bit surprising and a bit worrying.

• The Prevalence: About 18% of the pregnant women tested positive. That's roughly 1 in every 5 or 6 women. In a room of 100 pregnant women, 18 of them were carrying this infection without necessarily knowing it.
• The Age Group: The "ghost" loves the 25-to-35-year-old crowd. This makes sense because this is the "prime time" for having a family and being sexually active. It's like a party where the most active guests are the ones getting the most attention.
• Marital Status: Surprisingly, married women were more likely to have the infection than single women. The researchers explain this isn't because marriage is "dirty," but because their study focused on women who were already pregnant and sexually active. In this specific group, being married was the norm, so naturally, most of the infections were found there.
• Education: The women with a secondary school education were the most affected. The authors suggest this is because in this part of the world, girls often stop going to school early to get married and start families, so the "university" group is smaller and less represented in the study.

3. The Symptoms: The Silent Alarm

Usually, this bacteria is a "silent killer." It doesn't scream for attention. However, when it does speak up, it sounds like:

• Itchy vaginas (like a mosquito bite that won't go away).
• Strange discharge (like a leaky faucet).
• Pain in the lower belly (like a heavy weight sitting on your stomach).

4. The Danger: What Happens if We Ignore It?

If you leave a small leak in a boat, the whole ship can sink. Similarly, if this infection isn't treated, it can cause big problems for the pregnancy. The study found that women with the infection were more likely to face:

• Premature births: The baby arrives too early, before it's fully ready for the world.
• Spontaneous abortions: The pregnancy ends sadly before the baby is born.
• Pelvic pain: Long-term pain that lingers after the pregnancy.

5. The Big Picture: Why This Matters

The authors compare their findings to other studies. In rich countries like the USA, the infection rate is very low (around 2%). In their poor neighborhood in Kinshasa, it's much higher (18%).

Why the difference?

• The Diagnostic Tool: In the past, doctors used old, slow methods (like trying to grow the bacteria in a petri dish) which often missed the infection. This study used a modern, super-sensitive DNA test that catches the "ghost" even when it's hiding.
• The Environment: Poverty, lack of education, and limited access to healthcare make it harder to prevent and treat these infections.

The Takeaway

This study is like a lighthouse warning ships of a hidden reef. It tells us that in low-income areas of Kinshasa, this infection is common and dangerous, but it's often invisible.

The main lesson: We can't just wait for women to feel sick. We need to check everyone, especially pregnant women, using these modern, sensitive tests. If we find the "ghost" early, we can give them medicine to chase it away, protecting both the mother and the baby from a stormy future.

The researchers are calling for a change: Screening should be the rule, not the exception. If we do that, we can turn the tide against this silent epidemic.

Technical Summary

1. Problem Statement

Chlamydia trachomatis (CT) is a prevalent sexually transmitted infection (STI) that poses significant public health risks, particularly for women of reproductive age. While often asymptomatic, untreated CT can lead to severe complications including infertility, chronic pelvic inflammatory disease (PID), and adverse pregnancy outcomes such as miscarriage, preterm birth, and low birth weight.
In the Democratic Republic of Congo (DRC) and sub-Saharan Africa, the prevalence of CT in pregnant women is estimated to range widely (0–31%), yet reliable data is scarce. Existing diagnostic methods in these regions often rely on clinical symptoms or cell culture, which lack the sensitivity of molecular techniques. There is a critical need for accurate epidemiological data using modern diagnostic tools to inform screening and treatment protocols in resource-limited settings.

2. Methodology

Study Design and Setting:

• Type: Cross-sectional study conducted between June 2023 and December 2023.
• Location: A maternity ward in a low-income, western district of Kinshasa, DRC. This area is characterized by high delivery rates, low education levels, and high rates of sexual promiscuity among unmarried individuals.
• Population: Pregnant women attending prenatal consultations.

Inclusion/Exclusion Criteria:

• Included: Pregnant women who provided informed consent.
• Excluded: Women who had received antibiotics within two weeks prior to sampling or had sexual intercourse within 48 hours of sampling.
• Sample Quality Control: Samples with bacterial DNA concentration <95 ng/µl or 260/280 absorbance ratios indicating low purity (<1.94) were excluded.

Data Collection and Laboratory Procedures:

• Sample Collection: Endocervical swabs were collected using COPAN eNAT® FLOQSwabs® MiniTip 551C.
• DNA Extraction: Bacterial DNA was extracted from the cryptic plasmid using the QIAamp DNA Mini Kit.
• Molecular Diagnosis (PCR):
  • Target: A 101 bp fragment of the 16S rDNA from the C. trachomatis cryptic plasmid.
  • Primers: CTP1 and CTP2 (provided by Eurofins Scientific).
  • Thermocycling: 35 cycles involving denaturation (95°C), hybridization (55°C), and elongation (72°C).
  • Detection: Amplicons were visualized on a 2% agarose gel. A sample was considered positive if a 101 bp band matched the positive control.

Statistical Analysis:

• Data were analyzed using EPIINFO version 7.
• Prevalence was calculated with a 95% confidence interval.
• Associations between sociodemographic variables and CT positivity were assessed using bivariate and univariate logistic regression (significance set at p < 0.05).

3. Key Contributions

• First Molecular Study in DRC: This is the first study in the Democratic Republic of Congo to determine the prevalence of C. trachomatis in pregnant women using molecular diagnostics (PCR) rather than less sensitive methods like cell culture.
• Resource-Limited Context: It provides critical data from a specific low-income demographic in Kinshasa, highlighting the burden of STIs in settings with limited healthcare infrastructure.
• Clinical Correlation: The study links molecularly confirmed CT infection with specific clinical symptoms (vaginal itching, discharge) and adverse pregnancy outcomes (prematurity, spontaneous abortion).

4. Results

Study Population:

• Initial Samples: 239 cervical swabs were collected.
• Final Analyzed Cohort: 161 samples met the quality control criteria (DNA concentration and purity).
• Demographics: The majority of participants were aged 25–35 years (65.83%), married (83.22%), employed as traders (40.99%), and had a secondary education level (83.22%).

Prevalence and Risk Factors:

• Overall Prevalence: 18% (29 out of 161 women) tested positive for C. trachomatis.
• Age: The 25–35 age group had the highest infection rate (55.9% of positive cases), though the difference across age groups was not statistically significant (p = 0.34).
• Marital Status: Married women were more frequently infected than single women, though this was not statistically significant (p = 0.56).
• Education: Women with secondary education showed higher infection rates (14.9% of positives), but this was not statistically significant (p = 0.77).

Clinical Presentation and Complications:

• Symptoms: Among positive cases, the most common symptoms were vaginal itching (48.27%) and abnormal vaginal discharge/leukorrhea (24.13%). Other symptoms included dyspareunia and pelvic pain.
• Pregnancy Outcomes: Positive CT cases were associated with higher rates of:
  • Spontaneous abortions (17.24% vs. lower rates in negatives).
  • Premature births (34.48% vs. lower rates in negatives).
  • Cervicitis (61%).

5. Significance and Conclusion

• Public Health Impact: The study confirms that C. trachomatis is a significant public health challenge in Kinshasa's low-income pregnant population, with an 18% prevalence rate. This is higher than rates reported in some developed nations (e.g., 2% in the USA) but lower than some other African studies, potentially due to differences in diagnostic sensitivity (PCR vs. culture).
• Diagnostic Implications: The use of PCR revealed a higher prevalence than would likely be detected by clinical symptoms alone, reinforcing the need for molecular screening in prenatal care.
• Clinical Recommendations: The authors advocate for systematic early screening of pregnant women in resource-limited settings. Early detection is crucial to prevent vertical transmission (to the newborn causing pneumonia or conjunctivitis) and to mitigate obstetric complications like preterm birth and miscarriage.
• Limitations: The study was conducted in a single maternity ward, and the lack of statistical significance in some risk factors may be due to the sample size. However, the findings provide a strong baseline for future interventions.

Conclusion: Chlamydia trachomatis infection is common and often underdiagnosed among pregnant women in Kinshasa. The infection is strongly associated with vaginal symptoms and adverse pregnancy outcomes. Implementing molecular screening protocols is essential to improve maternal and fetal health outcomes in this region.